Key Takeaways
- • Private equity firms are increasingly pursuing medtech carve-outs and take-private transactions, according to commentary from Astorg's Olivier Lieven and Truist's Pete Cataldo.
- • Astorg's Olivier Lieven describes the growth across medtech as "very defensible," particularly in carefully selected niches.
- • Truist's Pete Cataldo says private equity interest continues in original equipment manufacturer (OEM) suppliers, and identifies women's health as an underinvested sector with attractive opportunities.
- • The source article does not provide deal values or specific transaction counts in the material available.
Summary
Private equity investors are showing sustained interest in medical technology, with a focus on carve-outs and take-private transactions, according to a feature published by the healthcare and deals coverage section of the source publication. The article, which is listed under the Deals, North America, US, Healthcare and Top Stories categories, is also republished by PEI Private Equity under the same headline.
Olivier Lieven of Astorg frames the appeal of the sector in terms of growth quality. He says there is "very defensible growth" across medtech, particularly for managers who select the right niches, and that this profile attracts considerable investor interest.
Pete Cataldo of Truist points to original equipment manufacturer suppliers as an area of continuing private equity focus. He also identifies women's health as a sector that has been underinvested, arguing that it presents "some nice opportunities."
The available material does not include specific deal values, named transactions, or fund sizes, so the scale of current carve-out and take-private activity cannot be quantified from this coverage.
Olivier Lieven of Astorg frames the appeal of the sector in terms of growth quality. He says there is "very defensible growth" across medtech, particularly for managers who select the right niches, and that this profile attracts considerable investor interest.
Pete Cataldo of Truist points to original equipment manufacturer suppliers as an area of continuing private equity focus. He also identifies women's health as a sector that has been underinvested, arguing that it presents "some nice opportunities."
The available material does not include specific deal values, named transactions, or fund sizes, so the scale of current carve-out and take-private activity cannot be quantified from this coverage.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.